The Effect of the Histone Deacetylase Inhibitor PXD101 on the Transcriptional Regulation of Diffuse Large B-Cell Lymphona
Diffuse Large B-cell Lymphoma (DLBCL) is the most common type of adult lymphoma. With current treatments this disease is curable, but remains fatal for 30-40% of patients. DLBCL is an extremely heterogeneous disease, and the lack of understanding about its variations makes it difficult to determine...
Main Author: | |
---|---|
Language: | en |
Published: |
The University of Arizona.
2012
|
Online Access: | http://hdl.handle.net/10150/244400 |